Healthcare provider profile · identity verified

Mikhail Ilych Akselrud, DO

Family Practice · BROOKLYN, NY · NPI 1407946833

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	248	56
Carvedilol	Carvedilol	171	26
Atorvastatin Calcium	Atorvastatin Calcium	160	32
Metformin Hcl	Metformin Hcl	145	27
Losartan Potassium	Losartan Potassium	139	32
Omeprazole	Omeprazole	105	27
Alprazolam	Alprazolam	102	13
Albuterol Sulfate Hfa	Albuterol Sulfate	99	19
Levothyroxine Sodium	Levothyroxine Sodium	81	14
Pantoprazole Sodium	Pantoprazole Sodium	81	14
Hydrochlorothiazide	Hydrochlorothiazide	79	13
Oxycodone Hcl	Oxycodone Hcl	74	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	66	suppressed
Telmisartan	Telmisartan	63	14
Januvia	Sitagliptin Phosphate	61	12
Gabapentin	Gabapentin	59	13
Zolpidem Tartrate	Zolpidem Tartrate	55	suppressed
Simvastatin	Simvastatin	51	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	suppressed
Atenolol	Atenolol	45	suppressed
Famotidine	Famotidine	43	11
Valsartan	Valsartan	41	suppressed
Clotrimazole	Clotrimazole	36	suppressed
Jardiance	Empagliflozin	36	suppressed
Novolog Flexpen	Insulin Aspart	36	suppressed
Ozempic	Semaglutide	36	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	34	suppressed
Diazepam	Diazepam	33	suppressed
Lisinopril	Lisinopril	32	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	30	suppressed
Metoprolol Succinate	Metoprolol Succinate	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Linzess	Linaclotide	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Meloxicam	Meloxicam	24	suppressed
Ammonium Lactate	Ammonium Lactate	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Furosemide	Furosemide	22	suppressed
Allopurinol	Allopurinol	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Eliquis	Apixaban	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Azithromycin	Azithromycin	17	13
Glimepiride	Glimepiride	17	suppressed
Metformin Er Gastric	Metformin Hcl	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Prednisone	Prednisone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Topiramate	Topiramate	12	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error